Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::404367469.png) E Lambrechts [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) on x XXX followers
Created: 2025-05-22 14:11:06 UTC

New #Genmab trial:

Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

$GMAB




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1925555019371192368/c:line.svg)

**Related Topics**
[$gmabco](/topic/$gmabco)
[$gmab](/topic/$gmab)
[checkpoint](/topic/checkpoint)
[approved](/topic/approved)

[Post Link](https://x.com/EgidiusLambrech/status/1925555019371192368)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

EgidiusLambrech Avatar E Lambrechts @EgidiusLambrech on x XXX followers Created: 2025-05-22 14:11:06 UTC

New #Genmab trial:

Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

$GMAB

XXX engagements

Engagements Line Chart

Related Topics $gmabco $gmab checkpoint approved

Post Link

post/tweet::1925555019371192368
/post/tweet::1925555019371192368